Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
William E. Rote Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
Jack Bendheim President and CEO · indirect
Sold on a plan 2×
$400.61K 9,660 at 41.47
30.2%
Planned (10b5-1)
3 Feb 2026
Michael S Williams Chief Executive Officer
Sold on a plan
$399.93K 19,017 at 21.03
2.7%
Planned (10b5-1)
3 Feb 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Robert Fauber President and CEO
Sold on a plan
$286.87K 575 at 498.90
0.9%
Planned (10b5-1)
3 Feb 2026
Anthony Folger Chief Financial Officer
Sold on a plan 2×
$240.01K 6,000 at 40.00
10.9%
Planned (10b5-1)
3 Feb 2026
Eric Richard Remer Chief Executive Officer
Sold on a plan 2×
$178.87K 16,403 at 10.90
0.6%
Planned (10b5-1)
3 Feb 2026
Ritadhwaja Jebens Singh EVP & Chief Digital Officer
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
Harlan S Robins Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
James J Claussen Executive Vice President & CFO
Sold on a plan
$149.16K 4,972 at 30.00
6.3%
Planned (10b5-1)
3 Feb 2026
Erika Ashley Fisher Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
Andrew G Inglis Chairman and CEO
Sold on a plan
$141.87K 103,554 at 1.37
2.4%
Planned (10b5-1)
3 Feb 2026
Oluyemi Okupe Chief Financial Officer
Sold on a plan
$139.11K 5,262 at 26.44
5.4%
Planned (10b5-1)
3 Feb 2026
Derek J Maetzold Pres. & Chief Exec. Officer
Sold on a plan
$127.72K 3,200 at 39.91
3.6%
Planned (10b5-1)
3 Feb 2026
Thomas C Indelicarto EVP, Gen Counsel & Secretary
Sold on a plan 2×
$124.04K 498 at 249.08
1.6%
Planned (10b5-1)
3 Feb 2026
Martina M.D. Flammer Chief Medical Officer
Sold on a plan
$123.84K 795 at 155.77
0.9%
Planned (10b5-1)
3 Feb 2026
David Foehr Senior VP, Finance and PAO
Sold on a plan 2×
$111.12K 5,556 at 20.00
22.7%
Planned (10b5-1)
3 Feb 2026
Sold on a plan 2×
$109.90K 10,000 at 10.99
0.5%
Planned (10b5-1)
3 Feb 2026
Jonathan Sheena Director
Sold on a plan
$100.38K 435 at 230.77
0.2%
Planned (10b5-1)
3 Feb 2026
Sold on a plan
$96.50K 10,500 at 9.19
14.4%
Planned (10b5-1)
3 Feb 2026
Tamara L Schulz Chief Accounting Officer
Sold on a plan
$91.31K 1,527 at 59.80
1.5%
Planned (10b5-1)
3 Feb 2026
Chad M. Smith Pres & COO, Better Mortgage · indirect
Sold on a plan
$83.80K 3,097 at 27.06
14.3%
Planned (10b5-1)
3 Feb 2026
Steven Yi See Remarks
Sold on a plan
$80.33K 8,000 at 10.04
0.3%
Planned (10b5-1)
3 Feb 2026
Nealesh D. Shah SVP and CFO
Sold on a plan
$74.57K 54,434 at 1.37
3.1%
Planned (10b5-1)
3 Feb 2026
Eugene Nonko Director · indirect
Sold on a plan
$67.42K 6,700 at 10.06
0.5%
Planned (10b5-1)
3 Feb 2026
Daniel S. Lorrain Chief Scientific Officer
Sold on a plan 2×
$62.31K 4,170 at 14.94
2.6%
Planned (10b5-1)
3 Feb 2026
Kristopher R Westbrooks President & COO
Sold on a plan
$62.06K 2,951 at 21.03
1.5%
Planned (10b5-1)
3 Feb 2026
Lyra Amber Schramm Chief People Officer
Sold on a plan
$55.99K 199 at 281.37
52.9%
Sold half or more
3 Feb 2026
Eugene Nonko Director
Sold on a plan
$54.33K 5,400 at 10.06
0.6%
Planned (10b5-1)
3 Feb 2026
Rebecca L Charlton SVP, Controller & CAO
Sold on a plan
$47.49K 843 at 56.34
5.7%
Planned (10b5-1)
3 Feb 2026
Erik Weaver EVP & Chief Financial Officer
Sold on a plan
$44.65K 1,493 at 29.90
1.9%
Planned (10b5-1)
3 Feb 2026
David Jedrzejek SVP and General Counsel
Sold on a plan
$44.06K 2,248 at 19.60
2.1%
Planned (10b5-1)
3 Feb 2026
Christiane Ohlgart Chief Financial Officer
Sold on a plan
$40.93K 507 at 80.73
5.8%
Planned (10b5-1)
3 Feb 2026
Timothy J. Sangiovanni SVP, Finance & Corp Controller
Sold on a plan
$27.55K 3,000 at 9.18
9.2%
Planned (10b5-1)
3 Feb 2026
Josh R. Marion SVP and General Counsel
Sold on a plan
$26.93K 19,656 at 1.37
9.1%
Planned (10b5-1)
3 Feb 2026
Ronald W. Glass VP & Chief Accounting Officer
Sold on a plan
$26.42K 19,285 at 1.37
5.3%
Planned (10b5-1)
3 Feb 2026
Jeanette Sellers SVP of Accounting
Sold on a plan
$24.85K 1,330 at 18.68
2.8%
Planned (10b5-1)
3 Feb 2026
Manish Sharma Chief Strategy & Services Ofcr
Sold on a plan
$24.54K 98 at 250.36
1.9%
Planned (10b5-1)
3 Feb 2026
Jan Malcolm Director
Sold on a plan
$23.71K 50 at 474.23
15.6%
Planned (10b5-1)
3 Feb 2026
Ian H. Siegel Chief Executive Officer · indirect
Sold on a plan
$21.83K 9,722 at 2.25
15.5%
Planned (10b5-1)
3 Feb 2026
Sold on a plan
$15.25K 25,000 at 0.61
25.0%
Planned (10b5-1)
3 Feb 2026
Ashley Still Director
Sold on a plan
$13.07K 63 at 207.42
2.7%
Planned (10b5-1)
3 Feb 2026
Melissa A Burgum Chief Accounting Officer
Sold on a plan
$3.76K 15 at 250.43
0.2%
Planned (10b5-1)
3 Feb 2026
Vincent Vultaggio PAO and PFO
Sold on a plan
$1.40K 556 at 2.52
0.3%
Planned (10b5-1)
2 Feb 2026
Kevin M Stein Director · indirect
Sold on a plan 32×
$68.53M 48,000 at 1,427.79
85.5%
Sold half or more
2 Feb 2026
Reed Hastings Director
Sold on a plan 3×
$32.70M 390,970 at 83.63
99.0%
Sold half or more
2 Feb 2026
Adena T Friedman Chair and CEO
Sold on a plan
$29.07M 300,000 at 96.91
13.5%
Planned (10b5-1)
2 Feb 2026
Christopher Swift Chairman and CEO
Sold on a plan 6×
$27.55M 201,938 at 136.41
50.9%
Sold half or more
2 Feb 2026
Steven Leonard Chapman CEO and President
Sold on a plan 6×
$19.68M 85,299 at 230.72
40.0%
Planned (10b5-1)
Showing 17,651–17,700 of 23,258. ← Newer Page 354 of 466 Older →